DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ inched 0.20% higher to $397.36 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.20% to 5,061.82 and Dow Jones Industrial Average falling 0.65% to 37,735.11.
Vertex Pharmaceuticals Inc. closed $51.04 short of its 52-week high ($448.40), which the company achieved on January 30th.
The stock outperformed some of its competitors Monday, as AbbVie Inc. $(ABBV)$ fell 0.38% to $161.67, Krystal Biotech Inc. (KRYS) fell 2.23% to $169.75, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 3.68% to $29.31.
Trading volume (1.4 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 15, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 15, 2024 16:43 ET (20:43 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments